-
Processa shoots for breast cancer label expansion for capecitabine combo
22 Jan 2024 16:50 GMT
… well as other treatments for breast cancer.”
Processa’s NGC-Cap … low doses of Roche’s Xeloda (capecitabine). The latter drug … FDA granted Roche approval for Xeloda in 2001 for the … as colon, gastroesophageal junction, and breast cancers.
In its NGC programme, …
-
Managing Chemo-Related Hand-Foot Syndrome
26 Mar 2024 19:31 GMT
… effects from drugs such as Xeloda (capecitabine) is important, especially … patients with breast cancer or gastrointestinal cancers who receive Xeloda may experience … that patients with breast cancer or gastrointestinal cancers taking Xeloda should be …
-
HER2+ Combo Shows Promise in Breast Cancer Brain Mets
07 Dec 2023 22:16 GMT
… unresectable or metastatic HER2-positive breast cancer, tucatinib (Tukysa, Seagen) and … added to trastuzumab and capecitabine (Xeloda, Genentech). In 2020, the … unresectable or metastatic HER2-positive breast cancer, including brain metastases.
To …
-
New drug combo fights breast cancer with brain metastases
07 Dec 2023 08:11 GMT
… trastuzumab and the chemotherapy capecitabine (Xeloda) significantly improved progression-free … advanced or metastatic HER2-positive breast cancer were enrolled and randomly … for patients with HER2-positive breast cancer brain metastases, most studies …
-
Tucatinib plus trastuzumab emtansine may benefit patients with advanced or metastatic HER2-positive breast cancer
06 Dec 2023 13:28 GMT
… trastuzumab and the chemotherapy capecitabine (Xeloda) significantly improved progression-free … advanced or metastatic HER2-positive breast cancer were enrolled and randomly … for patients with HER2-positive breast cancer brain metastases, most studies …
-
Limited treatment access hinders progress against triple-negative breast cancer
14 Sep 2023 02:25 GMT
… Korean Cancer Study Group’s Breast Cancer Committee.
Cancer immunotherapy Keytruda (pembrolizumab … who achieve complete eradication of breast cancer through preoperative chemotherapy enjoy an … a six-month medication of Xeloda. Consequently, the risk of …
-
Seagen's breast cancer therapy meets main goal in late-stage study
16 Aug 2023 12:47 GMT
… Seagen said on Wednesday its breast cancer therapy in combination with Roche … with Roche’s Herceptin and Xeloda in patients whose cancer has …
-
What medications are available to treat breast cancer?
31 Jan 2023 19:23 GMT
… hormone receptor-negative breast cancer, or triple-negative breast cancer, hormone therapy … 5-fluorouracil (5-FU)
capecitabine (Xeloda)
carboplatin (Paraplatin)
cyclophosphamide (Cytoxan … pill for breast cancer?
For people who have breast cancer that responds …
-
Judy Howell's sister died of breast cancer at age 36. When Howell developed aggressive breast cancer at age 70, the advances are so great that her...
09 Nov 2022 13:55 GMT
… negative matrix-producing metaplastic breast cancer.
Her breast oncologist, … hormone receptor-positive breast cancer cells, with estrogen … those with triple-negative breast cancer.”
Evolved Treatment
Howell … .
Howell also received Xeloda, a drug that …
-
AstraZeneca, Daiichi Sankyo's Enhertu delays breast cancer progression, meets study goals
15 Aug 2022 10:19 GMT
… :RHHBF)/capecitabine, marketed as Xeloda also by Roche; or GSK … unresectable and/or metastatic breast cancer previously treated with trastuzumab emtansine … programme in HER2-positive metastatic breast cancer," said Susan Galbraith, executive …